Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 11, 2020
Galmed Pharmaceuticals and MyBiotics Pharma have entered into a research and development collaboration agreement to identify and optimize the selected microbiome repertoire associated with the response to Aramchol.
read more
Wednesday, November 11, 2020
Centogene and Fujirebio Europe have entered a partnership to leverage LUMIPULSE G technology for large-scale COVID-19 antigen testing with further deployment in German airports.
read more
Wednesday, November 11, 2020
German independent research institute BioMed X has expanded its immunology research program with Janssen Research & Development.
read more
Friday, November 13, 2020
KDx has selected Acupath Laboratories to process urine specimens for a formal FDA trial that kicked off in Q3.
read more
Friday, November 13, 2020
Logan Instruments has officially launched their Permeation-Barrier Membrane (PB-M) into international markets.
read more
Friday, November 13, 2020
Flamma entered into an agreement with Gilead earlier this year to be part of the network of manufacturers contributing to the Veklury supply chain.
read more
Friday, November 13, 2020
WCG announced the VA is implementing WCG's IRBNet electronic submission and review system for more than 100 VA medical centers that have research programs.
read more
Monday, November 16, 2020
TCR2 Therapeutics has established a manufacturing partnership with ElevateBio, to leverage the technical capabilities at ElevateBio BaseCamp, a cell and gene therapy manufacturing facility based in Waltham, MA.
read more
Monday, November 16, 2020
Samsung Bioepis announced the initiation of Phase 1 clinical trial for SB16, the company's proposed biosimilar referencing Prolia (denosumab).
read more
Monday, November 16, 2020
Moderna announced the DSMB for the Phase 3 study of mRNA-1273 has informed the company the trial has met the statistical criteria pre-specified in the study protocol for efficacy, with a vaccine efficacy of 94.5%.
read more
Monday, November 16, 2020
Pharmaron Beijing has acquired 100% of the equity of Absorption Systems for up to US$137.5 million in cash.
read more
Monday, November 16, 2020
RhoFED was awarded a contract from the BARDA, part of the Office of the Assistant Secretary for Preparedness and Response at the HHS to manage a SDCC for BARDA’s Medical Countermeasures Clinical Studies Network.
read more
Monday, November 16, 2020
NNIT acquires US-based Excellis, a specialized global provider in end-to-end supply chain consulting services to the life sciences industry.
read more
Tuesday, November 17, 2020
XOMA has earned a milestone payment from Agenus related to Merck’s advancement of MK-4830 into a Phase 2 study in patients with advanced NSCLC.
read more
Tuesday, November 17, 2020
PhoreMost and Oxford Biomedica have entered into a discovery collaboration to develop next-generation CAR-T cell therapies.
read more